Clinical Trial Update: Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor [Phase 4]

View source ↗

Summary

Phase 4 trial assessing vorapaxar in patients with prior myocardial infarction treated with prasugrel and ticagrelor has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Vorapaxar (vorapaxar)

Snippet

Sponsor: University of Florida | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED | Results posted: 2020-08-25